Furthermore, co-treatment with AC-EO and siRNA-EGFR or cetuximab leads to a more effective downregulation of cell proliferation and the expression level of MMP-7 and -9 than individual treatment in B16F10 melanoma [133]. Here, EGFR is linked to melanoma.